HGEN stopped recruiting because they filled their trial. Topline results by Wednesday. They didn't get denied to do OLE. Doing OLEs after a trial is finished is not normal. Most companies just wait to see if they got an EUA. CytoDyn has a $99 million stockpile of leronlimab that they need to get rid of. Hence OLE.
Lenz and HGEN are failures, look at how the trial is panning out. No OLE or eIND. Leronlimab and the Cytodyn team will get the EUA very soon. What scientists back Lenz?